Israeli Pharmaceutical Companies See Decline in Shares

1 Mins read

Shares of Israeli pharmaceutical companies have experienced a drop in premarket trading on Monday in the aftermath of the recent attack by Hamas on Israel.

Teva Pharmaceutical Industries Ltd.

Israeli pharmaceutical giant, Teva Pharmaceutical Industries Ltd. (TEVA), has seen a 4% decrease in its shares.

Taro Pharmaceutical Industries Ltd.

Shares of Taro Pharmaceutical Industries Ltd. (TARO) have also been impacted, with a decrease of 2.6%.

Kamada Ltd.

Biopharmaceutical company, Kamada Ltd. (KMDA), has observed a significant decline of 6.1% in its stock value.

Protalix BioTheraputics Inc.

The stock of Protalix BioTheraputics Inc. (PLX) has experienced a decrease of 5.5%.

Protalix released a statement expressing their condolences and solidarity with the victims of the ongoing attacks in Israel. However, they reassured their employees, partners, and stockholders that their operations remain unaffected by the situation and that there will be no disruption to the supply of their products.

Compugen Ltd.

Drug discovery and development company, Compugen Ltd. (CGEN), has witnessed a 6.6% decrease in shares on Monday.

Gamida Cell Ltd.

Gamida Cell Ltd. (GMDA) has experienced a decline of 7.4% in premarket trades on Monday.

These recent developments highlight the impact of the attack on Israeli society, including its pharmaceutical industry.

Related posts

Alaska Air Group Inc. to Acquire Hawaiian Airlines

1 Mins read
Alaska Air Group Inc. has recently announced its plan to acquire Hawaiian Airlines in a deal worth approximately $1.9 billion. The transaction…

The State of the U.S. Labor Market

2 Mins read
This week, all eyes will be on the U.S. labor market as the Federal Reserve’s December meeting approaches. The release of November…

Ceres Power Holdings Faces Revenue Setback

1 Mins read
Ceres Power Holdings, a leading fuel-cell technology company, experienced a sharp decline in its shares on Friday. The company announced that its…

Leave a Reply

Your email address will not be published. Required fields are marked *